semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42499082
Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment.
Therapeutic role of semaglutide in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis of placebo-controlled trials with GRADE evidence assessment.
- 저자
- Suleman Khan, Asad Jamal, Maria Qadri, Ibrahim Aslam Zai, Asim Shah, Adil Ahmed
- 저널
- Medicine
- 공개일
- 2026 Jul 24
- 연구 유형
- 기타
- DOI
- 10.1097/MD.0000000000049916
문헌 요약
Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH), are leading causes of chronic liver disease worldwide. Despite the rising clinical burden, there are currently no approved pharmacologic therapies. Semaglutide, a glucagon-like peptide-1 receptor agonist with established metabolic and weight-loss benefi…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.